DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3鈥� carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
麻豆原创 Analysis and Insights: Global Sangers Sequencing Service 麻豆原创
The global Sangers Sequencing Service market is projected to grow from US$ 313 million in 2024 to US$ 502.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
Global Sanger Sequencing Service key players include Eurofins, Thermofisher, Genewiz, Nucleics, SciGenom Labs, etc. Global top five manufacturers hold a share about 70%. United States is the largest market, with a share about 25%, followed by Europe and China, both with a share about 20 percent. In terms of product, PCR amplicons is the largest segment, with a share about 60%. And in terms of application, the largest application is Institutions, followed by Bioscience Companies, Hospitals.
Report Covers:
This report presents an overview of global market for Sangers Sequencing Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sangers Sequencing Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sangers Sequencing Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sangers Sequencing Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sangers Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sangers Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Source BioScience
GenScript Biotech
Thermo Fisher Scientific
LGC Science Group
Fasteris
CeMIA
Quintara Biosciences
GenHunter
GENEWIZ
Nucleics
SciGenom Labs
Microsynth
Laragen
StarSEQ
Segment by Type
Shotgun Sequencing
Targeted Gene Sequencing
Others
Segment by Application
Academic and Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals and Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sangers Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sangers Sequencing Service companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sangers Sequencing Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Sangers Sequencing Service 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Shotgun Sequencing
1.2.3 Targeted Gene Sequencing
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Sangers Sequencing Service 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Academic and Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals and Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sangers Sequencing Service 麻豆原创 Perspective (2019-2030)
2.2 Global Sangers Sequencing Service Growth Trends by Region
2.2.1 Sangers Sequencing Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sangers Sequencing Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Sangers Sequencing Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Sangers Sequencing Service 麻豆原创 Dynamics
2.3.1 Sangers Sequencing Service Industry Trends
2.3.2 Sangers Sequencing Service 麻豆原创 Drivers
2.3.3 Sangers Sequencing Service 麻豆原创 Challenges
2.3.4 Sangers Sequencing Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sangers Sequencing Service by Players
3.1.1 Global Sangers Sequencing Service Revenue by Players (2019-2024)
3.1.2 Global Sangers Sequencing Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Sangers Sequencing Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sangers Sequencing Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Sangers Sequencing Service 麻豆原创 Concentration Ratio
3.4.1 Global Sangers Sequencing Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sangers Sequencing Service Revenue in 2023
3.5 Global Key Players of Sangers Sequencing Service Head office and Area Served
3.6 Global Key Players of Sangers Sequencing Service, Product and Application
3.7 Global Key Players of Sangers Sequencing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sangers Sequencing Service Breakdown Data by Type
4.1 Global Sangers Sequencing Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Sangers Sequencing Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Sangers Sequencing Service Breakdown Data by Application
5.1 Global Sangers Sequencing Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Sangers Sequencing Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Sangers Sequencing Service 麻豆原创 Size (2019-2030)
6.2 North America Sangers Sequencing Service 麻豆原创 Size by Type
6.2.1 North America Sangers Sequencing Service 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Sangers Sequencing Service 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Sangers Sequencing Service 麻豆原创 Share by Type (2019-2030)
6.3 North America Sangers Sequencing Service 麻豆原创 Size by Application
6.3.1 North America Sangers Sequencing Service 麻豆原创 Size by Application (2019-2024)
6.3.2 North America Sangers Sequencing Service 麻豆原创 Size by Application (2025-2030)
6.3.3 North America Sangers Sequencing Service 麻豆原创 Share by Application (2019-2030)
6.4 North America Sangers Sequencing Service 麻豆原创 Size by Country
6.4.1 North America Sangers Sequencing Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Sangers Sequencing Service 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Sangers Sequencing Service 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sangers Sequencing Service 麻豆原创 Size (2019-2030)
7.2 Europe Sangers Sequencing Service 麻豆原创 Size by Type
7.2.1 Europe Sangers Sequencing Service 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Sangers Sequencing Service 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Sangers Sequencing Service 麻豆原创 Share by Type (2019-2030)
7.3 Europe Sangers Sequencing Service 麻豆原创 Size by Application
7.3.1 Europe Sangers Sequencing Service 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe Sangers Sequencing Service 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe Sangers Sequencing Service 麻豆原创 Share by Application (2019-2030)
7.4 Europe Sangers Sequencing Service 麻豆原创 Size by Country
7.4.1 Europe Sangers Sequencing Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Sangers Sequencing Service 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Sangers Sequencing Service 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sangers Sequencing Service 麻豆原创 Size (2019-2030)
8.2 China Sangers Sequencing Service 麻豆原创 Size by Type
8.2.1 China Sangers Sequencing Service 麻豆原创 Size by Type (2019-2024)
8.2.2 China Sangers Sequencing Service 麻豆原创 Size by Type (2025-2030)
8.2.3 China Sangers Sequencing Service 麻豆原创 Share by Type (2019-2030)
8.3 China Sangers Sequencing Service 麻豆原创 Size by Application
8.3.1 China Sangers Sequencing Service 麻豆原创 Size by Application (2019-2024)
8.3.2 China Sangers Sequencing Service 麻豆原创 Size by Application (2025-2030)
8.3.3 China Sangers Sequencing Service 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Sangers Sequencing Service 麻豆原创 Size (2019-2030)
9.2 Asia Sangers Sequencing Service 麻豆原创 Size by Type
9.2.1 Asia Sangers Sequencing Service 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Sangers Sequencing Service 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Sangers Sequencing Service 麻豆原创 Share by Type (2019-2030)
9.3 Asia Sangers Sequencing Service 麻豆原创 Size by Application
9.3.1 Asia Sangers Sequencing Service 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia Sangers Sequencing Service 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia Sangers Sequencing Service 麻豆原创 Share by Application (2019-2030)
9.4 Asia Sangers Sequencing Service 麻豆原创 Size by Region
9.4.1 Asia Sangers Sequencing Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Sangers Sequencing Service 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Sangers Sequencing Service 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Sangers Sequencing Service 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Source BioScience
11.1.1 Source BioScience Company Details
11.1.2 Source BioScience Business Overview
11.1.3 Source BioScience Sangers Sequencing Service Introduction
11.1.4 Source BioScience Revenue in Sangers Sequencing Service Business (2019-2024)
11.1.5 Source BioScience Recent Developments
11.2 GenScript Biotech
11.2.1 GenScript Biotech Company Details
11.2.2 GenScript Biotech Business Overview
11.2.3 GenScript Biotech Sangers Sequencing Service Introduction
11.2.4 GenScript Biotech Revenue in Sangers Sequencing Service Business (2019-2024)
11.2.5 GenScript Biotech Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Sangers Sequencing Service Introduction
11.3.4 Thermo Fisher Scientific Revenue in Sangers Sequencing Service Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 LGC Science Group
11.4.1 LGC Science Group Company Details
11.4.2 LGC Science Group Business Overview
11.4.3 LGC Science Group Sangers Sequencing Service Introduction
11.4.4 LGC Science Group Revenue in Sangers Sequencing Service Business (2019-2024)
11.4.5 LGC Science Group Recent Developments
11.5 Fasteris
11.5.1 Fasteris Company Details
11.5.2 Fasteris Business Overview
11.5.3 Fasteris Sangers Sequencing Service Introduction
11.5.4 Fasteris Revenue in Sangers Sequencing Service Business (2019-2024)
11.5.5 Fasteris Recent Developments
11.6 CeMIA
11.6.1 CeMIA Company Details
11.6.2 CeMIA Business Overview
11.6.3 CeMIA Sangers Sequencing Service Introduction
11.6.4 CeMIA Revenue in Sangers Sequencing Service Business (2019-2024)
11.6.5 CeMIA Recent Developments
11.7 Quintara Biosciences
11.7.1 Quintara Biosciences Company Details
11.7.2 Quintara Biosciences Business Overview
11.7.3 Quintara Biosciences Sangers Sequencing Service Introduction
11.7.4 Quintara Biosciences Revenue in Sangers Sequencing Service Business (2019-2024)
11.7.5 Quintara Biosciences Recent Developments
11.8 GenHunter
11.8.1 GenHunter Company Details
11.8.2 GenHunter Business Overview
11.8.3 GenHunter Sangers Sequencing Service Introduction
11.8.4 GenHunter Revenue in Sangers Sequencing Service Business (2019-2024)
11.8.5 GenHunter Recent Developments
11.9 GENEWIZ
11.9.1 GENEWIZ Company Details
11.9.2 GENEWIZ Business Overview
11.9.3 GENEWIZ Sangers Sequencing Service Introduction
11.9.4 GENEWIZ Revenue in Sangers Sequencing Service Business (2019-2024)
11.9.5 GENEWIZ Recent Developments
11.10 Nucleics
11.10.1 Nucleics Company Details
11.10.2 Nucleics Business Overview
11.10.3 Nucleics Sangers Sequencing Service Introduction
11.10.4 Nucleics Revenue in Sangers Sequencing Service Business (2019-2024)
11.10.5 Nucleics Recent Developments
11.11 SciGenom Labs
11.11.1 SciGenom Labs Company Details
11.11.2 SciGenom Labs Business Overview
11.11.3 SciGenom Labs Sangers Sequencing Service Introduction
11.11.4 SciGenom Labs Revenue in Sangers Sequencing Service Business (2019-2024)
11.11.5 SciGenom Labs Recent Developments
11.12 Microsynth
11.12.1 Microsynth Company Details
11.12.2 Microsynth Business Overview
11.12.3 Microsynth Sangers Sequencing Service Introduction
11.12.4 Microsynth Revenue in Sangers Sequencing Service Business (2019-2024)
11.12.5 Microsynth Recent Developments
11.13 Laragen
11.13.1 Laragen Company Details
11.13.2 Laragen Business Overview
11.13.3 Laragen Sangers Sequencing Service Introduction
11.13.4 Laragen Revenue in Sangers Sequencing Service Business (2019-2024)
11.13.5 Laragen Recent Developments
11.14 StarSEQ
11.14.1 StarSEQ Company Details
11.14.2 StarSEQ Business Overview
11.14.3 StarSEQ Sangers Sequencing Service Introduction
11.14.4 StarSEQ Revenue in Sangers Sequencing Service Business (2019-2024)
11.14.5 StarSEQ Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Source BioScience
GenScript Biotech
Thermo Fisher Scientific
LGC Science Group
Fasteris
CeMIA
Quintara Biosciences
GenHunter
GENEWIZ
Nucleics
SciGenom Labs
Microsynth
Laragen
StarSEQ
听
听
*If Applicable.
